IPSEN – Buy-back programme – Art 5 of MAR – Week 49- 2025
| Aggregated presentation by day and by market
Statement of transactions in own shares from December 1st to December 05th 2025 |
||||||
| Name of the issue | Identity code of the issuer (Legal Entity Identifier) |
Day of the transaction | Identity code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/12/2025 | FR0010259150 | 200 | 124,05000 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/12/2025 | FR0010259150 | 831 | 123,81540 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/12/2025 | FR0010259150 | 100 | 124,40000 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/12/2025 | FR0010259150 | 1897 | 124,16958 | XPAR |
| 3028 | 124,07209 | |||||
Attachment
IPSEN – Buy-back programme – Art 5 of MAR – Week 49- 2025
| Aggregated presentation by day and by market
Statement of transactions in own shares from December 1st to December 05th 2025 |
||||||
| Name of the issue | Identity code of the issuer (Legal Entity Identifier) |
Day of the transaction | Identity code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/12/2025 | FR0010259150 | 200 | 124,05000 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/12/2025 | FR0010259150 | 831 | 123,81540 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/12/2025 | FR0010259150 | 100 | 124,40000 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/12/2025 | FR0010259150 | 1897 | 124,16958 | XPAR |
| 3028 | 124,07209 | |||||
Attachment
Related Press Releases
Ipsen announces that Beech Tree has obtained an exemption from the obligation to submit a public tender offer
Ipsen announces the availability of its 2025 Universal Registration Document
Ipsen – February 2026 – Monthly information relative to the total number of voting rights and shares composing the share...
Ipsen appoints Michelle C. Werner as EVP, President of North America
Ipsen S.A. publishes its 2025 Consolidated Financial Statements
Ipsen – January 2026 – Monthly information relative to the total number of voting rights and shares composing the share...
Ipsen nominates Peter Guenter to its Board of Directors
Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma
Ipsen – December 2025 – Monthly information relative to the total number of voting rights and shares composing the share...
Ipsen – Half year statement – 2025 12 31